Eli Lilly and Company
DRUG-DELIVERY SYSTEMS INCLUDING DRUG-DELIVERY DEVICE ASSEMBLIES FOR ATTACHING TO INFUSION HUBS
Last updated:
Abstract:
The present disclosure relates to a drug-delivery device that is attachable to an infusion set hub that has been pre-inserted into a patient's body. The pre-inserted infusion set hub may be configured to deliver a primary drug such as insulin or an insulin analog. The drug-delivery device may deliver a secondary drug such as a glucagon, an NS AID, or another type of insulin or insulin analog through a cannula of the infusion hub.
Status:
Application
Type:
Utility
Filling date:
8 Oct 2019
Issue date:
3 Feb 2022